My Quote Request
No products added yet
6505-01-267-5597
20 Products
TPN ELECTROLYTES
ELECTROLYTE CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505012675597
NSN
6505-01-267-5597
TPN ELECTROLYTES
ELECTROLYTE CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505012675597
NSN
6505-01-267-5597
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 16.050 MILLIGRAMS SODIUM CHLORIDE PER MILLILITER AND 16.550 MILLIGRAMS CALCIUM CHLORIDE PER MILLILITER AND 74.550 MILLIGRAMS POTASSIUM CHLORIDE PER MILLILITER AND 25.400 MILLIGRAMS MAGNESIUM CHLORIDE PER MILLILITER AND 121.000 MILLIGRAMS SODIUM ACETATE
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ELECTROLYTE CONCENTRATE FOR INJECTION 20ML UNIT 25S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE NEEDLE UNIT WITH PROTECTIVE COVER
SPECIAL FEATURES: SYRINGE COVER IS PLASTIC BALL OVER NEEDLE TO PREVENT MISUSE; FOR INJECTION INTO IV DEXTROSE SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: PER MILLILITER
Related Searches:
NDC00074-5882-19
ELECTROLYTE CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505012675597
NSN
6505-01-267-5597
NDC00074-5882-19
ELECTROLYTE CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505012675597
NSN
6505-01-267-5597
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 16.050 MILLIGRAMS SODIUM CHLORIDE PER MILLILITER AND 16.550 MILLIGRAMS CALCIUM CHLORIDE PER MILLILITER AND 74.550 MILLIGRAMS POTASSIUM CHLORIDE PER MILLILITER AND 25.400 MILLIGRAMS MAGNESIUM CHLORIDE PER MILLILITER AND 121.000 MILLIGRAMS SODIUM ACETATE
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ELECTROLYTE CONCENTRATE FOR INJECTION 20ML UNIT 25S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE NEEDLE UNIT WITH PROTECTIVE COVER
SPECIAL FEATURES: SYRINGE COVER IS PLASTIC BALL OVER NEEDLE TO PREVENT MISUSE; FOR INJECTION INTO IV DEXTROSE SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: PER MILLILITER
Related Searches:
MEVACOR
LOVASTATIN TABLETS
NSN, MFG P/N
6505012677925
NSN
6505-01-267-7925
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS LOVASTATIN ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEVACOR TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
Related Searches:
MEVACOR TABLETS
LOVASTATIN TABLETS
NSN, MFG P/N
6505012677925
NSN
6505-01-267-7925
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS LOVASTATIN ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEVACOR TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
Related Searches:
NDC00006-0731-28
LOVASTATIN TABLETS
NSN, MFG P/N
6505012677925
NSN
6505-01-267-7925
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS LOVASTATIN ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEVACOR TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
Related Searches:
NDC00029-6579-21
TICARCILLIN AND CLAVULANIC ACID FOR INJECTION,USP
NSN, MFG P/N
6505012677965
NSN
6505-01-267-7965
NDC00029-6579-21
TICARCILLIN AND CLAVULANIC ACID FOR INJECTION,USP
NSN, MFG P/N
6505012677965
NSN
6505-01-267-7965
MFG
KING PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 GRAMS TICARCILLIN EQUIVALENT AND 1.000 GRAMS CLAVULANIC ACID EQUIVALENT
FEATURES PROVIDED: STERILE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 31.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: PHARMACY BULK
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
TIMENTIN
TICARCILLIN AND CLAVULANIC ACID FOR INJECTION,USP
NSN, MFG P/N
6505012677965
NSN
6505-01-267-7965
TIMENTIN
TICARCILLIN AND CLAVULANIC ACID FOR INJECTION,USP
NSN, MFG P/N
6505012677965
NSN
6505-01-267-7965
MFG
KING PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 GRAMS TICARCILLIN EQUIVALENT AND 1.000 GRAMS CLAVULANIC ACID EQUIVALENT
FEATURES PROVIDED: STERILE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 31.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: PHARMACY BULK
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
000578
PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505012678982
NSN
6505-01-267-8982
000578
PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505012678982
NSN
6505-01-267-8982
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V PREDNISOLONE ACETATE ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
FEATURES PROVIDED: STERILE
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
Related Searches:
NDC00023-0180-01
PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505012678982
NSN
6505-01-267-8982
NDC00023-0180-01
PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505012678982
NSN
6505-01-267-8982
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V PREDNISOLONE ACETATE ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
FEATURES PROVIDED: STERILE
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
Related Searches:
PRED FORTE SUSPENSION
PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505012678982
NSN
6505-01-267-8982
PRED FORTE SUSPENSION
PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505012678982
NSN
6505-01-267-8982
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V PREDNISOLONE ACETATE ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
FEATURES PROVIDED: STERILE
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
Related Searches:
4B-78-77
WASHING SOLUTION,FR
NSN, MFG P/N
6505012679632
NSN
6505-01-267-9632
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 0.2 % DEXTROSE AND 0.9 % SODIUM CHLORIDE SOLUTION; TWELVE 1000 ML PLASTIC CONTAINERS PER PACKAGE; FOR USE AS A FINAL WASH SOLUTION FOR HIGH AND LOW GLYCEROL PROTOCOLS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: WASHING SOLUTION FROZEN BLOOD 1000 ML PLASTIC CONTAINER 12S
Related Searches:
ARALEN
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505012679662
NSN
6505-01-267-9662
ARALEN
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505012679662
NSN
6505-01-267-9662
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROQUINE PHOSPHATE TABLETS USP 500MG 25S BT
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ARALEN BY SANOFI/WINTHROP PHARM.
Related Searches:
ARALEN PHOSPHATE
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505012679662
NSN
6505-01-267-9662
ARALEN PHOSPHATE
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505012679662
NSN
6505-01-267-9662
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROQUINE PHOSPHATE TABLETS USP 500MG 25S BT
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ARALEN BY SANOFI/WINTHROP PHARM.
Related Searches:
ARALEN PHOSPHATE TABLETS
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505012679662
NSN
6505-01-267-9662
ARALEN PHOSPHATE TABLETS
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505012679662
NSN
6505-01-267-9662
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROQUINE PHOSPHATE TABLETS USP 500MG 25S BT
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ARALEN BY SANOFI/WINTHROP PHARM.
Related Searches:
NDC00024-0084-01
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505012679662
NSN
6505-01-267-9662
NDC00024-0084-01
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505012679662
NSN
6505-01-267-9662
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROQUINE PHOSPHATE TABLETS USP 500MG 25S BT
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ARALEN BY SANOFI/WINTHROP PHARM.
Related Searches:
NDC00143-2125-22
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505012679662
NSN
6505-01-267-9662
NDC00143-2125-22
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505012679662
NSN
6505-01-267-9662
MFG
WEST-WARD PHARMACEUTICAL CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROQUINE PHOSPHATE TABLETS USP 500MG 25S BT
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ARALEN BY SANOFI/WINTHROP PHARM.
Related Searches:
HYPAQUE-CYSTO
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012679663
NSN
6505-01-267-9663
HYPAQUE-CYSTO
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012679663
NSN
6505-01-267-9663
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE INJECTION USP 100ML BOTTLE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH RUBBER STOPPER,SINGLE DOSE
SPECIAL FEATURES: BOTTLE HAS A RATED CAPACITY OF NOT LESS THAN 300 ML
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00024-0735-10
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012679663
NSN
6505-01-267-9663
NDC00024-0735-10
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012679663
NSN
6505-01-267-9663
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE INJECTION USP 100ML BOTTLE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH RUBBER STOPPER,SINGLE DOSE
SPECIAL FEATURES: BOTTLE HAS A RATED CAPACITY OF NOT LESS THAN 300 ML
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00407-0735-10
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012679663
NSN
6505-01-267-9663
NDC00407-0735-10
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012679663
NSN
6505-01-267-9663
MFG
GE HEALTH DBA GE HEALTHCARE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE INJECTION USP 100ML BOTTLE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH RUBBER STOPPER,SINGLE DOSE
SPECIAL FEATURES: BOTTLE HAS A RATED CAPACITY OF NOT LESS THAN 300 ML
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
INAPSINE INJECTION
DROPERIDOL INJECTION,USP
NSN, MFG P/N
6505012681687
NSN
6505-01-268-1687
INAPSINE INJECTION
DROPERIDOL INJECTION,USP
NSN, MFG P/N
6505012681687
NSN
6505-01-268-1687
MFG
JANSSEN PHARMACEUTICA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS DROPERIDOL PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,JANSSEN
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: NONPYROGENIC
TOTAL PRIMARY CONTAINER QUANTITY: 10
